Physician

Adam S Kotowski, MD

According to 2025 Medicare claims, Adam Kotowski, MD (NPI: 1992813828) practices hematology/oncology in the Buffalo-Cheektowaga, NY market, with the plurality of this provider's patient population coming from Erie, NY. This provider's primary affiliated billing organization is RPCI ONCOLOGY PC (NPI: 1952703985; TIN: 461355351) and primary practice location at 14221-5269.

Kotowski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 339 traditional Medicare patients, billed 453,168 HCPCS/CPT codes, and received $3,113,171 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 944 prescription claims across 307 beneficiaries totaling $2,391,257 in drug costs, led by Jakafi (Ruxolitinib Phosphate). DME data shows 63 claims. Open Payments data shows 52 records totaling $4,318. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,640,171 to $3,113,171. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,077,427 to $2,391,257. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.0M$6.1M2015 Medicare payment: $1,640,171 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,495,190 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,185,313 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $4,766,082 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,184,488 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $6,097,005 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $5,926,755 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $4,816,848 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,663,294 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,113,171 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015309130,047$1,640,171
2016332125,411$2,495,190
201738882,536$3,185,313
201840154,705$4,766,082
2019482100,005$4,184,488
20203921,812,853$6,097,005
20214841,175,690$5,926,755
2022456917,421$4,816,848
2023453842,821$4,663,294
2024339453,168$3,113,171

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.2M$2.5M2015 Drug cost: $1,077,427 (USD; Tot_Drug_Cst)2016 Drug cost: $1,661,283 (USD; Tot_Drug_Cst)2017 Drug cost: $2,297,581 (USD; Tot_Drug_Cst)2018 Drug cost: $2,482,278 (USD; Tot_Drug_Cst)2019 Drug cost: $1,303,771 (USD; Tot_Drug_Cst)2020 Drug cost: $1,291,195 (USD; Tot_Drug_Cst)2021 Drug cost: $1,348,170 (USD; Tot_Drug_Cst)2022 Drug cost: $2,411,046 (USD; Tot_Drug_Cst)2023 Drug cost: $2,153,759 (USD; Tot_Drug_Cst)2024 Drug cost: $2,391,257 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153061,291$1,077,427
20163281,512$1,661,283
20173401,795$2,297,581
20183531,618$2,482,278
2019271905$1,303,771
2020220695$1,291,195
2021282793$1,348,170
20223481,205$2,411,046
20233331,087$2,153,759
2024307944$2,391,257

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$16K$33K2015 Medicare payment: $32,929 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $17,044 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $2,160 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,157 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $1,496 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,825 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R126$32,929
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R84$17,044
2021N/R74$2,160
2022N/R29$1,157
2023N/R39$1,496
2024N/R63$1,825

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more187362$92
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more134158$64
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's120167$12
36415Insertion of needle into vein for collection of blood sample100277$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count106467$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JakafiRuxolitinib Phosphate361,080$607,584
CalquenceAcalabrutinib Maleate16480$230,255
VerzenioAbemaciclib13364$190,212
LenalidomideLenalidomide11294$164,902
EliquisApixaban1287,620$141,303

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
A4222Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)NN/R21$873
J9190Injection, fluorouracil, 500 mgNN/R21$492
A4221Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)NN/R21$460

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.52$4,318Alnylam Pharmaceuticals Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam S. Kotowski, MD?

Tedicare shows public-source Medicare data for Adam S. Kotowski, MD (NPI 1992813828), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam S. Kotowski, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam S. Kotowski, MD?

Adam S. Kotowski, MD is linked to RPCI ONCOLOGY PC (billing NPI 1952703985) in the available physician profile data.

Does Adam S. Kotowski, MD have Open Payments data?

Adam S. Kotowski, MD has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.